Risk of stent thrombosis after sirolimus or paclitaxel eluting coronary stent implantation.
Moreno
Raul
R
Fernandez
Cristina
C
Sanchez-Recalde
Angel
A
Calvo
Luis
L
Galeote
Guillermo
G
Sanchez-Aquino
Rosa
R
Lopez-Sendon
Jose-Luis
JL
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D003328:Coronary Thrombosis; D006801:Humans; D017239:Paclitaxel / Q000627:therapeutic use*; D012307:Risk Factors; D020123:Sirolimus / Q000627:therapeutic use*; D015607:Stents
D000900:Anti-Bacterial Agents; D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel; D020123:Sirolimus